Minerva Neurosciences (NERV) Tops Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Minerva Neurosciences Reports Second Quarter 2015 Financial Results and Business Updates
August 5, 2015 7:30 AM EDTOpening of clinical sites in six countries builds momentum in MIN-101 Phase IIb schizophrenia trial
First patient dosed in Phase IIa study with MIN-117 in major depressive disorder
First patient dosed in Phase Ib study with MIN-202 as adjunctive treatment for major depressive disorder; MIN-202 data in insomnia presented at SLEEP meeting
Company adds to Board and management
Management to host conference call today at 8:30 a.m. Eastern Time
WALTHAM, Mass., Aug. 5, 2015 (GLOBE... More
